TrialAdvances in therapy2023

Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study.

Min Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.